| Literature DB >> 33420094 |
Renata Mancini Banin1, Meira Maria Forcelini Machado2, Iracema Senna de Andrade1, Lorenza Oliveira Testa Carvalho1, Bruna Kelly Sousa Hirata2, Heider Mendonça de Andrade2, Viviane da Silva Júlio2, Jéssica de Souza Figueiredo Borges Ribeiro2, Suzete Maria Cerutti2, Lila Missae Oyama1, Eliane Beraldi Ribeiro3, Mônica Marques Telles1.
Abstract
While several pieces of evidence link obesity and mood disorders in menopause, the mechanisms involved are not yet fully understood. We have previously demonstrated that Ginkgo biloba extract (GbE) both attenuated diet-induced obesity of male rats and restored serotonin-induced hypophagia in ovariectomized female rats. The present study aimed at exploring whether GbE treatment ameliorates ovariectomy-related obesity and anxious/depressive-like behaviours. Wistar female rats were either ovariectomized (OVX) or sham-operated (Sham). After 2 months, either 500 mg/kg of GbE or vehicle were administered daily by gavage for 14 days. Anxious/depressive-like behaviours were assessed by the Elevated Plus Maze and the Forced Swim Tests, respectively. Ovariectomy caused high visceral adiposity, hyperleptinemia, and hypercholesterolemia, and increased the anxiety index (p = 0.048 vs. Sham + GbE) while it decreased the latency to immobility (p = 0.004 vs. Sham). GbE treatment in OVX rats improved body composition, adiponectin levels and blood lipid profile. It also reduced the anxiety index (p = 0.004) and increased the latency to immobility (p = 0.003) of OVX rats. Linear regression analysis demonstrated that leptin (p = 0.047) and total cholesterol levels (p = 0.022) were associated with anxious-like behaviours while body adiposity (p = 0.00005) was strongly associated with depressive-like behaviours. The results showed that GbE therapy was effective in attenuating the deleterious effects of ovariectomy on body composition, lipid profile, and anxious/depressive-like behaviours. Further studies are warranted to better understand the therapeutic potential of GbE in menopause.Entities:
Year: 2021 PMID: 33420094 PMCID: PMC7794418 DOI: 10.1038/s41598-020-78528-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379